Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion

Fri, 07th Jul 2023 16:55

(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking.

It was a better day for the CAC 40 in Paris and DAX 40 in Frankfurt, as well as the FTSE 250 in London. A stronger pound held back the FTSE 100.

The FTSE 100 index ended 23.56 points lower, or 0.3%, at 7,256.94. The FTSE 250 closed up 87.51 points, or 0.5%, at 18,003.97, while the AIM All-Share ended up 0.85 of a point, 0.1%, at 741.71.

For the week, the FTSE 100 lost 3.7%, the FTSE 250 shed 2.2% and the AIM All-Share fell 1.6%.

The Cboe UK 100 closed down 0.3% at 723.16, the Cboe UK 250 ended down 0.1% at 15,762.63, and the Cboe Small Companies fell 0.4% at 13,498.22.

In European equities on Friday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt added 0.5%.

"Despite modest gains for the likes of the FTSE 250, DAX and CAC 40, the FTSE 100 has struggled close to its March lows with health care and utilities acting as a ball and chain on the day, and as for the performance on the week it's been the worst week since the sharp falls we saw in March," CMC Markets analyst Michael Hewson commented.

Drugmaker AstraZeneca lost 2.1%, while Severn Trent and United Utilities gave back 2.2% and 1.7%, among the worst FTSE 100 performers.

A stronger pound also kept a lid on the blue-chip index, which is stacked with international earners.

Sterling was quoted at USD1.2832 late Friday afternoon, jumping from USD1.2690 at the London equities close on Thursday. The pound traded around its best level since June 19.

The euro traded at USD1.0949, higher than USD1.0858. Against the yen, the dollar was quoted at JPY142.27, down versus JPY144.23.

The dollar lost some momentum after the latest reading of the US labour market was cooler than expected.

According to the US Bureau of Labor Statistics, total non-farm payroll employment increased by 209,000 in June, decelerating from a revised rise of 306,000 in May.

June's figure came below expectations. According to FXStreet-cited consensus, 225,000 jobs were expected to be added last month.

The data came a day after numbers from payroll processor ADP showed US private sector employment grew by almost half a million jobs. Employment grew by 497,000 in June, rising from 278,000 in May.

What followed was some bond market chaos. The yield on the 10-year bond spiked as high as 4.08%. The two-year Treasury yield stretched as high as 5.12% on Thursday.

The weaker jobs report took some needle off government bond yields on Friday, however. The reading is unlikely to make the Federal Reserve change course, however, due to pay growth remaining robust.

Over the past 12 months, average hourly earnings increased 4.4% in June, unchanged from a month prior. This was slightly above expectations of a 4.2% increase, according to FXStreet-cited consensus.

"The slowing in payrolls alone might have given the Fed pause at their meeting later this month, but the overshoot in hourly earnings, and the upward revision to the May print, means that a hike now has to be our base case; it would take a zero core CPI print now to keep the Fed on hold. For the record, we think this hike will be a mistake, Pantheon Macroeconomics analyst Ian Shepherdson commented.

"A Fed willing to extrapolate the recent trends and take leading indicators - as well as the lags in policy - seriously, would not hike again. This is not that Fed. But the data will overtake the hawks by the end of the summer; we would be very surprised to see a further hike in September."

US stocks were mixed at the time of the European close. The Dow Jones Industrial Average fell 0.1%, the S&P 500 added 0.1% and the Nasdaq Composite climbed 0.3%.

In London, Coca-Cola HBC added 5.1%. After a stronger-than-expected finish to the first half of the year, the drinks bottler upgraded its earnings expectations for the full year.

The company now expects organic earnings before interest and tax growth of between 9% to 12% for 2023. Previously, Coca-Cola HBC had expected Ebit growth of up to 3% or a decline of up to 3%.

OSB Group tumbled 29% as it said it will take as much as a GBP180 million hit to first-half results, because customers are acting more quickly than expected to refinance their mortgages at favourable rates.

OSB, which stands for OneSavings Bank, said that as its mortgage customers reach the end of their initial fixed term, they are choosing to refinance earlier than expected and therefore spend less time on the higher reversion rate. This rate is linked to the Bank of England's bank base rate and has been rising over the past year as the central bank hikes UK interest rates.

"As the first half of 2023 progressed, the group observed a step change in the behaviour of Precise Mortgages owner-occupied and buy-to-let customers reaching the end of their initial fixed term," OSB explained.

OSB said it now expects customers to spend an average of five months on the higher reversion rate, which it said it is a reduction from its previous expectation without saying what that had been. As result of the reduced time spent at the higher rates, OSB said it will make a negative effective interest rate adjustment of GBP160 million to GBP180 million on an underlying basis against first-half results.

YouGov closed up 2.8%. It raised GBP51.2 million through a placing to go towards the acquisition of GfK's consumer panel business.

GfK's consumer panel business is focused on household purchase data, with panels across 16 European countries, consisting of over 100,000 households.

The London-based research and data analytics group said that the EUR315 million deal would not only extend its offering into the fast-moving consumer goods sector, but would help expand its offering to US clients.

Gold was quoted at USD1,929.07 an ounce late Friday, higher than USD1,909.01 on Thursday. Brent oil was trading at USD77.47 a barrel, higher than USD75.23.

Monday's economic calendar as Chinese inflation data overnight. Chancellor Andrew Bailey and Bank of England Governor Andrew Bailey speak at the yearly Mansion House event, meanwhile.

The local corporate calendar has quarterly numbers from self-storage firm Big Yellow Group on Monday.

This time next week, investors will be digesting the first batch of quarterly earnings from US banking stocks, with Citigroup, JPMorgan Chase and Wells Fargo reporting before the opening bell in New York.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.